Home
About
Overview
Sharing Data
ORCID
Help
History (10)
Protein Tyrosine Phosphatase, Non-Receptor Type 11
Carbohydrates
Decoding cellular mechanism of recombinant adeno-associated virus (rAAV) and engineering host-cell factories toward intensified viral vector manufacturing.
Principal Investigator
Immune Toxicities in AAV Gene Therapy: Overview for Clinicians.
See All 10 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Immune Toxicities in AAV Gene Therapy: Overview for Clinicians.
Parajuli S, Gallagher T, Flotte TR. Immune Toxicities in AAV Gene Therapy: Overview for Clinicians. Int J Mol Sci. 2026 Mar 31; 27(7).
View in:
PubMed
subject areas
Adaptive Immunity
Animals
Dependovirus
Genetic Therapy
Genetic Vectors
Humans
Immunity, Innate
authors with profiles
Terence R Flotte MD